Development and Internal Validation of a Four‐Predictor Nomogram for In‐Stent Restenosis After Drug‐Eluting Stent Implantation in Patients With Overweight/Obesity
Catheterization and Cardiovascular Interventions · 2026
DOI: 10.1002/ccd.70300 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Guo-Biao Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The First People's Hospital of Fuzhou City, Fuzhou, China. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Nomograms, Percutaneous Coronary Intervention, Coronary Restenosis. Die Arbeit nennt 35 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
In‐stent restenosis (ISR) after drug‐eluting stent (DES) implantation remains clinically relevant in patients with elevated body mass index (BMI). This study aimed to develop and internally validate a simple nomogram for ISR risk after DES in patients with overweight/obesity.
Aims
To develop and internally validate a simple nomogram for predicting in‐stent restenosis (ISR) after drug‐eluting stent (DES) implantation in patients with overweight or obesity.
Methods
A single‐center retrospective cohort (2018–2023) of adults with BMI ≥ 25 kg/m² receiving first DES was analyzed. ISR was defined as ≥ 50% diameter stenosis within the stent or within 5 mm of its edges on follow‐up angiography. Patients were randomly split 70/30 into training and validation cohorts. Four clinically prespecified predictors—smoking, diabetes, total stent length, and stent diameter—were entered into multivariable logistic regression to derive a nomogram. Performance was evaluated by AUC, calibration plots with Hosmer–Lemeshow testing, bootstrapping, and decision curve analysis.
Results
A total of 468 high BMI patients were included, among whom 49 experienced ISR. Multivariate logistic regression analysis revealed smoking, diabetes, stent total length, and stent diameter as factors associated with ISR occurrence. The Nomogram model demonstrated strong predictive performance in both the training and validation sets, with C‐index values of 0.753 and 0.729, respectively. Calibration curves and decision curve analysis further confirmed the reliability and clinical utility of the model.
Conclusion
A four‐variable nomogram provides pragmatic ISR risk stratification after DES in patients with overweight/obesity, supporting individualized follow‐up and secondary prevention. External validation and prospective evaluation are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The First People's Hospital of Fuzhou City, Fuzhou, China.
- Department of Infectious Disease, Fifth People's Hospital of Ganzhou, Ganzhou, China.
- Department of Intensive Care Unit, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
ORCID-Profile: Song-Mao Ouyang
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Li, G. B., Zhu, D. Q., & Ouyang, S. M. (2026). Development and Internal Validation of a Four‐Predictor Nomogram for In‐Stent Restenosis After Drug‐Eluting Stent Implantation in Patients With Overweight/Obesity. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70300
Vancouver
Li GB, Zhu DQ, Ouyang SM. Development and Internal Validation of a Four‐Predictor Nomogram for In‐Stent Restenosis After Drug‐Eluting Stent Implantation in Patients With Overweight/Obesity. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70300
BibTeX
@article{Li2026,
author = {Li, Guo-Biao and Zhu, Da-Qing and Ouyang, Song-Mao},
title = {Development and Internal Validation of a Four‐Predictor Nomogram for In‐Stent Restenosis After Drug‐Eluting Stent Implantation in Patients With Overweight/Obesity},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70300}
}
EUVIMED